Warning letter
Holles Laboratories Inc.: warning letter of Apr 4, 2001
FDA warning letter UCM069516 · New England District Office
Key facts
| Reference number | UCM069516 |
|---|---|
| Company | Holles Laboratories Inc. |
| Subject | Quality System Regulation/Fluoresoft 0.35%/Adulterated |
| Issue date | Apr 4, 2001 |
| Posted date | Apr 4, 2001 |
| Issuing office | New England District Office |
| Product type | Unknown |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Cohasset |
| Inspection ZIP | 02025-1133 |
| Inspection start date | Mar 8, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: